NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Nov 2019
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Priority Review
POTASSIUM PHOSPHATES (potassium phosphates) by Fresenius Kabi is tissues, including critical roles in nucleic acid structure, energy storage and transfer, cell signaling, cell membrane composition and structure, acid-base balance, mineral homeostasis, and bone mineralization. First approved in 2019.
Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Potassium phosphates is an intravenous solution that replaces critical electrolytes and minerals in patients with deficiencies. The drug works by restoring phosphate and potassium levels essential for nucleic acid structure, energy metabolism, cell signaling, and bone mineralization. It is used in hospital and clinical settings to correct severe electrolyte imbalances.
Peak15.4 years to LOE
Product is in peak commercial phase with established market presence; brand team likely at full operational scale with stable headcount.
Mechanism of Action
tissues, including critical roles in nucleic acid structure, energy storage and transfer, cell signaling, cell membrane composition and structure, acid-base balance, mineral homeostasis, and bone mineralization.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on potassium phosphates offers career stability in a niche but essential IV category with no direct competitive pressure and strong patent protection through 2041. The mature, hospitalized-care focus means roles emphasize account management, clinical education, and supply chain expertise rather than launch activities or expansion trials.
Hospital Account Manager
Worked on POTASSIUM PHOSPHATES at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.